Denali Therapeutics Ownership 2024 | Who Owns Denali Therapeutics Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

39.24%

Insider Ownership

13.71%

Retail Ownership

47.04%

Institutional Holders

108.00

Denali Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAILLIE GIFFORD & CO10.22%0.22%14,041,228-219,496-1.54%288,125,999Mar 31, 2024
BLACKROCK INC.8.88%0.01%12,199,856656,4105.69%250,341,043Mar 31, 2024
VANGUARD GROUP INC7.98%0.00%10,968,293133,8101.24%225,069,372Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP6.02%0.03%8,269,949995,23213.68%169,699,354Mar 31, 2024
STATE STREET CORP4.60%0.01%6,323,872837,92415.27%129,765,853Mar 31, 2024
CAPITAL RESEARCH GLOBAL INVESTORS4.40%0.03%6,049,9573,140,429107.94%124,145,118Mar 31, 2024
TEMASEK HOLDINGS (PRIVATE) LTD4.15%0.65%5,706,345-1,189,647-17.25%117,094,199Mar 31, 2024
CRESTLINE MANAGEMENT, LP3.79%9.45%5,210,732-450,000-7.95%106,924,221Mar 31, 2024
BAKER BROS. ADVISORS LP2.72%0.96%3,731,6951,124,49943.13%76,574,381Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC2.01%0.01%2,759,633100,3373.77%56,636,392Mar 31, 2024
MARSHALL WACE, LLP1.56%0.07%2,146,379478,98228.73%44,043,696Mar 31, 2024
BANK OF NEW YORK MELLON CORP1.29%0.01%1,777,907-92,720-4.96%36,482,644Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.16%0.00%1,594,333-979,988-38.07%32,716,000Mar 31, 2024
CREDIT SUISSE AG/1.14%0.03%1,566,246-9,975-0.63%32,139,369Mar 31, 2024
CAMBER CAPITAL MANAGEMENT LP1.09%0.75%1,500,0001,500,000100.00%30,780,000Mar 31, 2024
CITADEL ADVISORS LLC0.99%0.01%1,365,0281,296,9181904.15%28,010,374Mar 31, 2024
FLAGSHIP PIONEERING INC.0.99%1.84%1,364,516-955,452-41.18%27,999,868Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP0.97%0.01%1,332,950213,32219.05%27,352,134Mar 31, 2024
CASDIN CAPITAL, LLC0.95%1.98%1,300,000--26,676,000Mar 31, 2024
FMR LLC0.90%0.00%1,232,522590,86992.09%25,291,348Mar 31, 2024

Denali Therapeutics's largest institutional shareholder is BAILLIE GIFFORD & CO, holding 10.22% of the company's total share outstanding, currently valued at $288.13M. The top 10 institutional shareholders own together 54.79% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARCH VENTURE MANAGEMENT, LLC0.28%9.75%381,249--7,823,229Mar 31, 2024
CRESTLINE MANAGEMENT, LP3.79%9.45%5,210,732-450,000-7.95%106,924,221Mar 31, 2024
CASDIN CAPITAL, LLC0.95%1.98%1,300,000--26,676,000Mar 31, 2024
ALTITUDE CREST PARTNERS INC.0.15%1.84%209,613209,613100.00%4,301,259Mar 31, 2024
FLAGSHIP PIONEERING INC.0.99%1.84%1,364,516-955,452-41.18%27,999,868Mar 31, 2024
YIHENG CAPITAL MANAGEMENT, L.P.0.84%1.31%1,150,684--23,612,036Mar 31, 2024
BAKER BROS. ADVISORS LP2.72%0.96%3,731,6951,124,49943.13%76,574,381Mar 31, 2024
CAMBER CAPITAL MANAGEMENT LP1.09%0.75%1,500,0001,500,000100.00%30,780,000Mar 31, 2024
TEMASEK HOLDINGS (PRIVATE) LTD4.15%0.65%5,706,345-1,189,647-17.25%117,094,199Mar 31, 2024
CLARIUS GROUP, LLC0.29%0.56%392,21813,9563.69%8,048,313Mar 31, 2024
PIER CAPITAL, LLC0.13%0.49%172,331-1,888-1.08%3,536,232Mar 31, 2024
IRONWOOD INVESTMENT MANAGEMENT LLC0.03%0.36%36,06418,126101.05%740,033Mar 31, 2024
CERCANO MANAGEMENT LLC0.46%0.36%625,000--12,825,000Mar 31, 2024
PDT PARTNERS, LLC0.12%0.31%158,384125,484381.41%3,250,040Mar 31, 2024
GILDER GAGNON HOWE & CO LLC0.85%0.30%1,172,785-46,607-3.82%24,065,558Mar 31, 2024
ARTAL GROUP S.A.0.37%0.26%502,899-300,000-37.36%10,319,487Mar 31, 2024
HARVEST INVESTMENT SERVICES, LLC0.02%0.23%27,97827,978100.00%574,108Mar 31, 2024
BAILLIE GIFFORD & CO10.22%0.22%14,041,228-219,496-1.54%288,125,999Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.15%0.20%211,017211,017100.00%4,330,069Mar 31, 2024
PIER 88 INVESTMENT PARTNERS LLC0.03%0.20%39,970-5,270-11.65%820,184Mar 31, 2024

The largest Denali Therapeutics shareholder by % of total assets is ARCH VENTURE MANAGEMENT, LLC. The company owns 381.25K shares of Denali Therapeutics (DNLI), representing 9.75% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAPITAL RESEARCH GLOBAL INVESTORS4.40%0.03%6,049,9573,140,429107.94%124,145,118Mar 31, 2024
CAMBER CAPITAL MANAGEMENT LP1.09%0.75%1,500,0001,500,000100.00%30,780,000Mar 31, 2024
CITADEL ADVISORS LLC0.99%0.01%1,365,0281,296,9181904.15%28,010,374Mar 31, 2024
BAKER BROS. ADVISORS LP2.72%0.96%3,731,6951,124,49943.13%76,574,381Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP6.02%0.03%8,269,949995,23213.68%169,699,354Mar 31, 2024
HOLOCENE ADVISORS, LP0.63%0.06%860,948860,948100.00%17,666,653Mar 31, 2024
STATE STREET CORP4.60%0.01%6,323,872837,92415.27%129,765,853Mar 31, 2024
BLACKROCK INC.8.88%0.01%12,199,856656,4105.69%250,341,043Mar 31, 2024
FMR LLC0.90%0.00%1,232,522590,86992.09%25,291,348Mar 31, 2024
GOLDMAN SACHS GROUP INC0.66%0.00%904,361510,556129.65%18,557,488Mar 31, 2024
MARSHALL WACE, LLP1.56%0.07%2,146,379478,98228.73%44,043,696Mar 31, 2024
FISHER ASSET MANAGEMENT, LLC0.34%0.00%469,169466,43617066.81%9,627,347Mar 31, 2024
BANK OF AMERICA CORP /DE/0.62%0.00%851,976393,33885.76%17,482,547,000Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.28%0.00%390,616390,616100.00%8,015,440Mar 31, 2024
WOODLINE PARTNERS LP0.37%0.10%508,565310,981157.39%10,435,754Mar 31, 2024
CITIGROUP INC0.28%0.01%382,416241,140170.69%7,847,176Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP0.97%0.01%1,332,950213,32219.05%27,352,134Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.15%0.20%211,017211,017100.00%4,330,069Mar 31, 2024
ALTITUDE CREST PARTNERS INC.0.15%1.84%209,613209,613100.00%4,301,259Mar 31, 2024
ABRDN PLC0.38%0.02%516,019191,19058.86%10,588,710Mar 31, 2024

As of Mar 31 2024, Denali Therapeutics's largest institutional buyer is CAPITAL RESEARCH GLOBAL INVESTORS. The company purchased 3.14M stocks of DNLI, valued at $124.15M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FEDERATED HERMES, INC.----1,351,900-100.00%-Mar 31, 2024
TEMASEK HOLDINGS (PRIVATE) LTD4.15%0.65%5,706,345-1,189,647-17.25%117,094,199Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.16%0.00%1,594,333-979,988-38.07%32,716,000Mar 31, 2024
FLAGSHIP PIONEERING INC.0.99%1.84%1,364,516-955,452-41.18%27,999,868Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.----644,406-100.00%-Mar 31, 2024
BRAIDWELL LP----461,769-100.00%-Mar 31, 2024
CRESTLINE MANAGEMENT, LP3.79%9.45%5,210,732-450,000-7.95%106,924,221Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.01%0.00%13,796-425,422-96.86%283,094Mar 31, 2024
EAGLE ASSET MANAGEMENT INC----315,520-100.00%-Mar 31, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)0.03%0.00%43,245-304,958-87.58%887,387Mar 31, 2024
ARTAL GROUP S.A.0.37%0.26%502,899-300,000-37.36%10,319,487Mar 31, 2024
MITSUBISHI UFJ TRUST & BANKING CORP----246,190-100.00%-Mar 31, 2024
BAILLIE GIFFORD & CO10.22%0.22%14,041,228-219,496-1.54%288,125,999Mar 31, 2024
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM----176,131-100.00%-Mar 31, 2024
BARCLAYS PLC0.11%0.00%151,560-172,459-53.23%3,110,000Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC----161,946-100.00%-Mar 31, 2024
SCHRODER INVESTMENT MANAGEMENT GROUP----154,000-100.00%-Mar 31, 2024
NEUBERGER BERMAN GROUP LLC----144,461-100.00%-Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.03%0.00%37,749-133,513-77.96%774,609Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC0.05%0.00%72,105-119,538-62.38%1,479,595Mar 31, 2024

As of Mar 31 2024, Denali Therapeutics's biggest institutional seller is FEDERATED HERMES, INC.. The company sold -1.35M shares of DNLI, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CAMBER CAPITAL MANAGEMENT LP1.09%0.75%1,500,0001,500,000100.00%30,780,000Mar 31, 2024
HOLOCENE ADVISORS, LP0.63%0.06%860,948860,948100.00%17,666,653Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.15%0.20%211,017211,017100.00%4,330,069Mar 31, 2024
ALTITUDE CREST PARTNERS INC.0.15%1.84%209,613209,613100.00%4,301,259Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.09%0.01%127,270127,270100.00%2,611,580Mar 31, 2024
D. E. SHAW & CO., INC.0.08%0.00%116,265116,265100.00%2,385,758Mar 31, 2024
EDGESTREAM PARTNERS, L.P.0.08%0.11%112,118112,118100.00%2,300,661Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.08%0.00%104,640104,640100.00%2,147,213Mar 31, 2024
ALGERT GLOBAL LLC0.06%0.07%82,00082,000100.00%1,683,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.05%0.00%69,80069,800100.00%1,432,296Mar 31, 2024
PEAK6 INVESTMENTS LLC0.04%0.00%54,60054,600100.00%1,120,392Mar 31, 2024
UBS OCONNOR LLC0.04%0.00%50,00050,000100.00%30,000Mar 31, 2024
BANK OF MONTREAL /CAN/0.03%0.00%42,28842,288100.00%881,282Mar 31, 2024
EP WEALTH ADVISORS, LLC0.03%0.01%40,50040,500100.00%831,060Mar 31, 2024
EISLER CAPITAL (US) LLC0.03%0.02%34,48034,480100.00%707,530Mar 31, 2024
LPL FINANCIAL LLC0.02%0.00%34,08534,085100.00%699,424Mar 31, 2024
HARVEST INVESTMENT SERVICES, LLC0.02%0.23%27,97827,978100.00%574,108Mar 31, 2024
TWO SIGMA ADVISERS, LP0.02%0.00%21,90021,900100.00%449,388Mar 31, 2024
NEOS INVESTMENT MANAGEMENT LLC0.02%0.03%21,64821,648100.00%444,217Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.01%0.00%18,40018,400100.00%377,568Mar 31, 2024
AQR CAPITAL MANAGEMENT LLC0.01%0.00%11,00111,001100.00%225,741Mar 31, 2024
MACKENZIE FINANCIAL CORP0.01%0.00%10,56010,560100.00%216,691Mar 31, 2024
PEAK6 INVESTMENTS LLC0.01%0.00%10,00010,000100.00%205,200Mar 31, 2024
GROUP ONE TRADING, L.P.0.01%0.00%8,4558,455100.00%173,497Mar 31, 2024
QUARRY LP0.01%0.03%7,0007,000100.00%143,640Mar 31, 2024
FERNWOOD INVESTMENT MANAGEMENT, LLC0.00%0.03%5,0005,000100.00%102,600,000Mar 31, 2024
SIMPLEX TRADING, LLC0.00%0.00%4,9284,928100.00%101,000Mar 31, 2024
HEADLANDS TECHNOLOGIES LLC0.00%0.02%4,2954,295100.00%88,133Mar 31, 2024
PACER ADVISORS, INC.0.00%0.00%2,0252,025100.00%41,553Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.00%0.01%2,0002,000100.00%41,040Mar 31, 2024
0.00%0.02%784784100.00%16,088Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC0.00%0.00%153153100.00%3,139Mar 31, 2024
FINANCIAL SYNERGIES WEALTH ADVISORS, INC.-0.00%3636100.00%739,000Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC--11100.00%21,000Mar 31, 2024

Denali Therapeutics's largest new institutional shareholder by number of shares is CAMBER CAPITAL MANAGEMENT LP, purchased 1.50M shares, valued at $30.78M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FEDERATED HERMES, INC.----1,351,900-100.00%-Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.----644,406-100.00%-Mar 31, 2024
BRAIDWELL LP----461,769-100.00%-Mar 31, 2024
EAGLE ASSET MANAGEMENT INC----315,520-100.00%-Mar 31, 2024
MITSUBISHI UFJ TRUST & BANKING CORP----246,190-100.00%-Mar 31, 2024
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM----176,131-100.00%-Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC----161,946-100.00%-Mar 31, 2024
SCHRODER INVESTMENT MANAGEMENT GROUP----154,000-100.00%-Mar 31, 2024
NEUBERGER BERMAN GROUP LLC----144,461-100.00%-Mar 31, 2024
PATHWAY CAPITAL MANAGEMENT, LP----69,450-100.00%-Mar 31, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC----65,105-100.00%-Mar 31, 2024
HARBOR CAPITAL ADVISORS, INC.----60,304-100.00%-Mar 31, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND----46,000-100.00%-Mar 31, 2024
HRT FINANCIAL LP----44,292-100.00%-Mar 31, 2024
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO----30,428-100.00%-Mar 31, 2024
CAPTION MANAGEMENT, LLC----30,000-100.00%-Mar 31, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD----27,429-100.00%-Mar 31, 2024
VELA INVESTMENT MANAGEMENT, LLC----26,145-100.00%-Mar 31, 2024
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.----24,318-100.00%-Mar 31, 2024
LEVIN CAPITAL STRATEGIES, L.P.----24,000-100.00%-Mar 31, 2024
BARCLAYS PLC----22,500-100.00%-Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC----18,327-100.00%-Mar 31, 2024
ARTHUR M. COHEN & ASSOCIATES, LLC----10,564-100.00%-Mar 31, 2024
QUEST PARTNERS LLC----9,965-100.00%-Mar 31, 2024
BRANDYWINE MANAGERS, LLC----9,601-100.00%-Mar 31, 2024
AQUATIC CAPITAL MANAGEMENT LLC----8,300-100.00%-Mar 31, 2024
TAO CAPITAL MANAGEMENT LP----3,042-100.00%-Mar 31, 2024
WALLEYE CAPITAL LLC----1,600-100.00%-Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC----309-100.00%-Mar 31, 2024
MORTON BROWN FAMILY WEALTH, LLC----298-100.00%-Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----77-100.00%-Mar 31, 2024
GLASSMAN WEALTH SERVICES----29-100.00%-Mar 31, 2024
QUADRANT CAPITAL GROUP LLC----19-100.00%-Mar 31, 2024
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC----11-100.00%-Mar 31, 2024

Denali Therapeutics's largest sold out institutional shareholder by shares sold is FEDERATED HERMES, INC., sold -1.35M shares, valued at -, as of undefined.

Denali Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
BNY MELLON VARIABLE INVESTMENT FUND0.76%183,99217,80010.71%Mar 31, 2024
HARTFORD HLS SERIES FUND II INC0.52%128,223--Dec 31, 2023
Tema ETF Trust0.48%21,64821,648-Feb 29, 2024
HSBC FUNDS0.44%14,320--Jan 31, 2024
NEW ECONOMY FUND0.25%1,141,8001,141,800-Feb 29, 2024
TEKLA LIFE SCIENCES INVESTORS0.19%110,331--Dec 31, 2023
TEKLA HEALTHCARE INVESTORS0.19%214,498--Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS0.15%72,022--Dec 31, 2023
T. Rowe Price Health Sciences Fund, Inc.0.10%517,185-260,396-33.49%Dec 31, 2023
VANGUARD SPECIALIZED FUNDS0.09%5,100,454--Jan 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.08%1,197,891-3,830-0.32%Dec 31, 2023
ALGER FUNDS0.08%74,209--Jan 31, 2024
PRUDENTIAL SECTOR FUNDS, INC.0.08%159,975--Feb 29, 2024
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.0.08%41,150--Dec 31, 2023
VELA Funds0.08%25,3585,88730.23%Dec 31, 2023
Humankind Benefit Corp0.07%1,57827020.64%Dec 31, 2023
T. Rowe Price Quantitative Management Funds, Inc.0.07%257,800-34,700-11.86%Dec 31, 2023
Voya VARIABLE PRODUCTS TRUST0.07%19,8242421.24%Dec 31, 2023
Voya EQUITY TRUST0.05%77,6848,22711.84%Feb 29, 2024
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)0.05%350,000--Dec 31, 2023
CORNERCAP GROUP OF FUNDS /VA/0.04%3,241--Sep 30, 2022
AMG FUNDS III0.04%7,155--Feb 29, 2024
WASATCH FUNDS TRUST0.04%380,29782,18427.57%Mar 31, 2024
BlackRock Health Sciences Trust II0.04%111,300--Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.04%17,9571710.96%Dec 31, 2023
T. Rowe Price Small-Cap Value Fund, Inc.0.04%289,938-149,200-33.98%Dec 31, 2023
SMALLCAP WORLD FUND INC0.04%2,512,75929,2051.18%Dec 31, 2023
Federated Hermes MDT Series0.04%87,096--Jan 31, 2024
FIDELITY ADVISOR SERIES VII0.03%281,664--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.03%215,12214,7827.38%Dec 31, 2023
BlackRock Advantage SMID Cap Fund, Inc.0.03%5,386-2,826-34.41%Dec 29, 2023
T. Rowe Price Tax-Efficient Funds, Inc.0.03%2,500--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.03%70,000--Dec 31, 2023
PRUDENTIAL JENNISON BLEND FUND, INC.0.03%16,396--Feb 29, 2024
VANGUARD INDEX FUNDS0.02%11,027,6601,940,53721.35%Dec 31, 2023
VANGUARD EXPLORER FUND0.02%200,354--Jan 31, 2024
Calvert Responsible Index Series, Inc.0.02%25,982--Dec 31, 2023
VANGUARD WORLD FUND0.02%3,910,667-137,179-3.39%Feb 29, 2024
Vericimetry Funds0.02%1,600--Dec 31, 2023
Northern Lights Variable Trust0.01%14,684--Dec 31, 2023
T. Rowe Price Equity Series, Inc.0.01%24,383-11,488-32.03%Dec 31, 2023
Harbor ETF Trust0.01%60,4697,90115.03%Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,697--Dec 31, 2023
BARON SELECT FUNDS0.01%129,200--Dec 31, 2023
FIDELITY COMMONWEALTH TRUST0.01%34,8315581.63%Feb 29, 2024
BNY Mellon Strategic Funds, Inc.0.01%22,761--Mar 31, 2024
ALPS ETF Trust0.01%105,7348,6628.92%Feb 29, 2024
JNL VARIABLE FUND LLC0.01%43,646-5,376-10.97%Mar 31, 2020
Fidelity Central Investment Portfolios LLC0.01%140,000--Feb 29, 2024
Nushares ETF Trust0.01%47,340--Jan 31, 2024
PROFESSIONALLY MANAGED PORTFOLIOS0.01%36,364--Feb 29, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.01%15,391--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.01%1,140,343-5,024-0.44%Feb 29, 2024
Calvert Variable Products, Inc.0.00%12,2304924.19%Dec 31, 2023
LORD ABBETT SECURITIES TRUST0.00%22,119--Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.00%16,132--Jan 31, 2024
Bernstein Fund Inc0.00%41,960--Dec 31, 2023
ProFunds0.00%35,93816,89688.73%Jan 31, 2024
SCHWAB STRATEGIC TRUST0.00%653,47726,5524.24%Feb 29, 2024
SunAmerica Specialty Series0.00%1,791-145-7.49%Apr 30, 2021
FIDELITY SELECT PORTFOLIOS0.00%200,069-88,900-30.76%Feb 29, 2024
BAILLIE GIFFORD FUNDS0.00%30,985-6,207-16.69%Dec 29, 2023
Fidelity Commonwealth Trust II0.00%18,724--Aug 31, 2023
ETFis Series Trust I0.00%3,54049516.26%Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%68,961--Dec 31, 2023
FEDERATED HERMES INSURANCE SERIES0.00%10,400--Dec 31, 2023
BNY MELLON FUNDS TRUST0.00%158,149158,149-Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND0.00%37,500--Dec 31, 2023
Direxion Shares ETF Trust0.00%309,131129,02271.64%Jan 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%6,528--Dec 31, 2023
PFM Multi-Manager Series Trust0.00%1,300--Dec 31, 2023
Voya VARIABLE PORTFOLIOS INC0.00%47,2972410.51%Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%18,234-2,290-11.16%Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%5,840-277-4.53%Dec 31, 2023
Principal Exchange-Traded Funds0.00%15,561-1,280-7.60%Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%21,892--Feb 29, 2024
AMG Funds IV0.00%3,561--Jan 31, 2024
Advisors' Inner Circle Fund III0.00%17,3813221.89%Jan 31, 2024
FIDELITY COVINGTON TRUST0.00%15,623-1-0.01%Feb 29, 2024
FIDELITY CONTRAFUND0.00%71,928--Dec 31, 2023
PRINCIPAL VARIABLE CONTRACTS FUNDS INC0.00%41,10013,20047.31%Dec 31, 2023
LORD ABBETT SERIES FUND INC0.00%22,260--Dec 31, 2023
OHIO NATIONAL FUND INC0.00%19,493--Dec 31, 2023
TIMOTHY PLAN0.00%4,295--Mar 31, 2024
NORTHWESTERN MUTUAL SERIES FUND INC0.00%113,301--Dec 31, 2023
STEWARD FUNDS, INC.0.00%2,180--Jan 31, 2024
SSGA FUNDS0.00%377--Feb 29, 2024
Dimensional ETF Trust0.00%377,91715,2634.21%Jan 31, 2024
TIAA-CREF LIFE FUNDS0.00%1,799--Dec 31, 2023
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.0.00%5,900-1,500-20.27%Dec 29, 2023
NEW COVENANT FUNDS0.00%2,631--Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%608,006142,50630.61%Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%42,2363,4048.77%Dec 31, 2023
VANGUARD HORIZON FUNDS0.00%9,921--Dec 31, 2023
HARTFORD MUTUAL FUNDS II INC0.00%68,926-6,125-8.16%Jan 31, 2024
JOHN HANCOCK INVESTMENT TRUST0.00%35,03121,765164.07%Jan 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%35,21514,15967.24%Dec 31, 2023
Janus Detroit Street Trust0.00%60,189--Jan 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%26,298240.09%Jan 31, 2024
EQ ADVISORS TRUST0.00%331,801-5,506-1.63%Dec 31, 2023

Denali Therapeutics's largest mutual fund holder by % of total assets is "BNY MELLON VARIABLE INVESTMENT FUND", owning 183.99K shares, compromising 0.76% of its total assets.

Denali Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24108-49.77%
31 Dec, 2321510.26%
30 Sep, 23195-0.51%
30 Jun, 23196-1.01%
31 Mar, 231980.51%
31 Dec, 221971.03%
30 Sep, 221959.55%
30 Jun, 22178-0.56%
31 Mar, 22179-13.94%
31 Dec, 21208-1.89%
30 Sep, 21212-
30 Jun, 21212-4.07%
31 Mar, 212215.74%
31 Dec, 2020922.22%
30 Sep, 2017121.28%
30 Jun, 2014110.16%
31 Mar, 2012818.52%
31 Dec, 19108-5.26%
30 Sep, 191142.70%
30 Jun, 19111-1.77%
31 Mar, 1911326.97%
31 Dec, 188914.10%
30 Sep, 187816.42%
30 Jun, 186715.52%
31 Mar, 185828.89%
31 Dec, 1745-

As of 31 Mar 24, 108 institutions are holding Denali Therapeutics's shares, representing a decrease of -49.77% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2453,910,296-51.28%
31 Dec, 23110,657,5002.78%
30 Sep, 23107,663,1720.58%
30 Jun, 23107,046,2140.51%
31 Mar, 23106,499,1590.73%
31 Dec, 22105,722,74114.64%
30 Sep, 2292,222,269-0.38%
30 Jun, 2292,572,5506.92%
31 Mar, 2286,577,5571.75%
31 Dec, 2185,090,3570.26%
30 Sep, 2184,869,7355.32%
30 Jun, 2180,584,0190.17%
31 Mar, 2180,445,506-9.19%
31 Dec, 2088,583,0747.24%
30 Sep, 2082,605,122-0.01%
30 Jun, 2082,614,2272.90%
31 Mar, 2080,286,51113.53%
31 Dec, 1970,718,121-0.76%
30 Sep, 1971,256,758-0.16%
30 Jun, 1971,368,6283.40%
31 Mar, 1969,021,0051.36%
31 Dec, 1868,095,2511.68%
30 Sep, 1866,971,8857.66%
30 Jun, 1862,206,5241.84%
31 Mar, 1861,082,8985.05%
31 Dec, 1758,144,610-

Denali Therapeutics (DNLI) has 53.91M shares outstanding as of 31 Mar 24, down -51.28% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2439.24%0.61%
31 Dec, 2380.39%1.30%
30 Sep, 2378.56%1.28%
30 Jun, 2378.41%1.29%
31 Mar, 2378.01%1.23%
31 Dec, 2279.56%1.43%
30 Sep, 2274.69%1.32%
30 Jun, 2275.26%1.51%
31 Mar, 2270.58%1.45%
31 Dec, 2169.65%1.43%
30 Sep, 2169.71%1.58%
30 Jun, 2166.44%1.50%
31 Mar, 2166.55%1.22%
31 Dec, 2073.72%1.25%
30 Sep, 2076.85%1.26%
30 Jun, 2078.15%1.27%
31 Mar, 2078.39%1.43%
31 Dec, 1973.97%1.34%
30 Sep, 1974.33%1.33%
30 Jun, 1974.74%1.42%
31 Mar, 1972.67%1.39%
31 Dec, 1872.21%1.41%
30 Sep, 1871.50%1.59%
30 Jun, 1866.96%1.44%
31 Mar, 1868.20%1.62%
31 Dec, 1764.92%-

As of 31 Mar 24, Denali Therapeutics is held by 39.24% institutional shareholders, representing a 0.61% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2457-46.23%
31 Dec, 23106-
30 Sep, 23106-2.75%
30 Jun, 23109-4.39%
31 Mar, 231143.64%
31 Dec, 221100.92%
30 Sep, 2210919.78%
30 Jun, 229110.98%
31 Mar, 2282-23.36%
31 Dec, 21107-6.14%
30 Sep, 21114-
30 Jun, 21114-4.20%
31 Mar, 21119-0.83%
31 Dec, 2012025.00%
30 Sep, 209612.94%
30 Jun, 2085-2.30%
31 Mar, 208793.33%
31 Dec, 1945-13.46%
30 Sep, 1952-17.46%
30 Jun, 1963-5.97%
31 Mar, 196717.54%
31 Dec, 1857-
30 Sep, 185723.91%
30 Jun, 18469.52%
31 Mar, 1842-6.67%
31 Dec, 1745-

57 institutional shareholders have increased their position in DNLI stock as of 31 Mar 24 compared to 106 in the previous quarter (a -46.23% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2436-47.83%
31 Dec, 236921.05%
30 Sep, 235711.76%
30 Jun, 23514.08%
31 Mar, 2349-5.77%
31 Dec, 2252-3.70%
30 Sep, 22541.89%
30 Jun, 2253-15.87%
31 Mar, 2263-
31 Dec, 2163-1.56%
30 Sep, 21646.67%
30 Jun, 2160-11.76%
31 Mar, 21681.49%
31 Dec, 206736.73%
30 Sep, 204944.12%
30 Jun, 203461.90%
31 Mar, 2021-43.24%
31 Dec, 193748.00%
30 Sep, 19258.70%
30 Jun, 1923-11.54%
31 Mar, 192623.81%
31 Dec, 182190.91%
30 Sep, 1811-15.38%
30 Jun, 181362.50%
31 Mar, 188-
31 Dec, 17--

36 institutional shareholders have reduced their position in DNLI stock as of 31 Mar 24 compared to 69 in the previous quarter (a -47.83% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24108-49.77%53,910,296-51.28%39.24%0.61%57-46.23%36-47.83%
31 Dec, 2321510.26%110,657,5002.78%80.39%1.30%106-6921.05%
30 Sep, 23195-0.51%107,663,1720.58%78.56%1.28%106-2.75%5711.76%
30 Jun, 23196-1.01%107,046,2140.51%78.41%1.29%109-4.39%514.08%
31 Mar, 231980.51%106,499,1590.73%78.01%1.23%1143.64%49-5.77%
31 Dec, 221971.03%105,722,74114.64%79.56%1.43%1100.92%52-3.70%
30 Sep, 221959.55%92,222,269-0.38%74.69%1.32%10919.78%541.89%
30 Jun, 22178-0.56%92,572,5506.92%75.26%1.51%9110.98%53-15.87%
31 Mar, 22179-13.94%86,577,5571.75%70.58%1.45%82-23.36%63-
31 Dec, 21208-1.89%85,090,3570.26%69.65%1.43%107-6.14%63-1.56%
30 Sep, 21212-84,869,7355.32%69.71%1.58%114-646.67%
30 Jun, 21212-4.07%80,584,0190.17%66.44%1.50%114-4.20%60-11.76%
31 Mar, 212215.74%80,445,506-9.19%66.55%1.22%119-0.83%681.49%
31 Dec, 2020922.22%88,583,0747.24%73.72%1.25%12025.00%6736.73%
30 Sep, 2017121.28%82,605,122-0.01%76.85%1.26%9612.94%4944.12%
30 Jun, 2014110.16%82,614,2272.90%78.15%1.27%85-2.30%3461.90%
31 Mar, 2012818.52%80,286,51113.53%78.39%1.43%8793.33%21-43.24%
31 Dec, 19108-5.26%70,718,121-0.76%73.97%1.34%45-13.46%3748.00%
30 Sep, 191142.70%71,256,758-0.16%74.33%1.33%52-17.46%258.70%
30 Jun, 19111-1.77%71,368,6283.40%74.74%1.42%63-5.97%23-11.54%
31 Mar, 1911326.97%69,021,0051.36%72.67%1.39%6717.54%2623.81%
31 Dec, 188914.10%68,095,2511.68%72.21%1.41%57-2190.91%
30 Sep, 187816.42%66,971,8857.66%71.50%1.59%5723.91%11-15.38%
30 Jun, 186715.52%62,206,5241.84%66.96%1.44%469.52%1362.50%
31 Mar, 185828.89%61,082,8985.05%68.20%1.62%42-6.67%8-
31 Dec, 1745-58,144,610-64.92%-45---

Denali Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 17, 2024SATO VICKI Ldirector-S-SaleSell1,674$20.39$34.13K116,369
Apr 17, 2024SATO VICKI Ldirector-S-SaleSell1,666$18.29$30.47K118,043
Apr 02, 2024Krognes Steve E.director-S-SaleSell92,500$20.50$1.90M47,341
Mar 19, 2024SATO VICKI Ldirector-S-SaleSell1,666$20.10$33.49K119,709
Feb 20, 2024SATO VICKI Ldirector-S-SaleSell1,666$18.37$30.60K121,375
Feb 15, 2024Krognes Steve E.director-S-SaleSell2,750$17.29$47.55K139,841
Feb 15, 2024Watts Ryan J.director, officer President and CEOS-SaleSell9,589$17.29$165.79K238,067
Feb 15, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell2,784$17.29$48.14K145,010
Feb 15, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell1,405$17.79$24.99K143,605
Feb 15, 2024Schuth Alexander O.officer COFO and SecretaryS-SaleSell2,716$17.29$46.96K207,469
Feb 15, 2024Schuth Alexander O.officer COFO and SecretaryS-SaleSell20,128$17.66$355.46K187,341
Jan 18, 2024SATO VICKI Ldirector-S-SaleSell1,666$18.42$30.69K123,041
Jan 12, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell4,668$19.02$88.79K147,794
Jan 11, 2024Watts Ryan J.director, officer President and CEOS-SaleSell7,818$19.78$154.64K2,268,363
Jan 09, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell9,972$19.43$193.76K198,777
Jan 09, 2024Krognes Steve E.director-S-SaleSell3,208$19.43$62.33K142,591
Jan 09, 2024Schuth Alexander O.officer COFO and SecretaryS-SaleSell9,972$19.43$193.76K539,307

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 17, 2024SATO VICKI Ldirector-S-SaleSell1,674$20.39$34.13K116,369
Apr 17, 2024SATO VICKI Ldirector-S-SaleSell1,666$18.29$30.47K118,043
Apr 02, 2024Krognes Steve E.director-S-SaleSell92,500$20.50$1.90M47,341
Mar 29, 2024Watts Ryan J.director, officer President and CEOG-GiftSell40,000--2,202,604
Mar 19, 2024SATO VICKI Ldirector-S-SaleSell1,666$20.10$33.49K119,709
Feb 20, 2024SATO VICKI Ldirector-S-SaleSell1,666$18.37$30.60K121,375
Feb 15, 2024Krognes Steve E.director-S-SaleSell2,750$17.29$47.55K139,841
Feb 15, 2024Watts Ryan J.director, officer President and CEOS-SaleSell9,589$17.29$165.79K238,067
Feb 15, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell2,784$17.29$48.14K145,010
Feb 15, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell1,405$17.79$24.99K143,605
Feb 15, 2024Schuth Alexander O.officer COFO and SecretaryS-SaleSell2,716$17.29$46.96K207,469
Feb 15, 2024Schuth Alexander O.officer COFO and SecretaryS-SaleSell20,128$17.66$355.46K187,341
Feb 12, 2024Schuth Alexander O.officer COFO and SecretaryM-ExemptSell50,000$0.68$34.00K145,078
Jan 18, 2024SATO VICKI Ldirector-S-SaleSell1,666$18.42$30.69K123,041
Jan 12, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell4,668$19.02$88.79K147,794
Jan 11, 2024Watts Ryan J.director, officer President and CEOS-SaleSell7,818$19.78$154.64K2,268,363
Jan 09, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell9,972$19.43$193.76K198,777
Jan 09, 2024Krognes Steve E.director-S-SaleSell3,208$19.43$62.33K142,591
Jan 09, 2024Schuth Alexander O.officer COFO and SecretaryS-SaleSell9,972$19.43$193.76K539,307

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 17, 2024SATO VICKI Ldirector-S-SaleSell1,674$20.39$34.13K116,369
Apr 17, 2024SATO VICKI Ldirector-S-SaleSell1,666$18.29$30.47K118,043
Apr 02, 2024Krognes Steve E.director-S-SaleSell92,500$20.50$1.90M47,341
Mar 29, 2024Watts Ryan J.director, officer President and CEOG-GiftSell40,000--2,202,604
Mar 19, 2024SATO VICKI Ldirector-S-SaleSell1,666$20.10$33.49K119,709
Feb 20, 2024SATO VICKI Ldirector-S-SaleSell1,666$18.37$30.60K121,375
Feb 15, 2024Krognes Steve E.director-S-SaleSell2,750$17.29$47.55K139,841
Feb 15, 2024Watts Ryan J.director, officer President and CEOS-SaleSell9,589$17.29$165.79K238,067
Feb 15, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell2,784$17.29$48.14K145,010
Feb 15, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell1,405$17.79$24.99K143,605
Feb 15, 2024Schuth Alexander O.officer COFO and SecretaryS-SaleSell2,716$17.29$46.96K207,469
Feb 15, 2024Schuth Alexander O.officer COFO and SecretaryS-SaleSell20,128$17.66$355.46K187,341
Feb 12, 2024Schuth Alexander O.officer COFO and SecretaryM-ExemptBuy50,000$0.68$34.00K210,185
Feb 12, 2024Schuth Alexander O.officer COFO and SecretaryM-ExemptSell50,000$0.68$34.00K145,078
Jan 18, 2024SATO VICKI Ldirector-S-SaleSell1,666$18.42$30.69K123,041
Jan 12, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell4,668$19.02$88.79K147,794
Jan 11, 2024Watts Ryan J.director, officer President and CEOS-SaleSell7,818$19.78$154.64K2,268,363
Jan 09, 2024Ho Caroleofficer Chief Medical OfficerS-SaleSell9,972$19.43$193.76K198,777
Jan 09, 2024Krognes Steve E.director-S-SaleSell3,208$19.43$62.33K142,591
Jan 09, 2024Schuth Alexander O.officer COFO and SecretaryS-SaleSell9,972$19.43$193.76K539,307

The last insider sell of Denali Therapeutics's stock was made by SATO VICKI L on May 17 2024, selling 1,674 shares at $20.39 per share (valued at $34.13K).

Denali Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-3-
Q1 202471741.18%
Q4 2023-3-
Q3 202321910.53%
Q2 20232614185.71%
Q1 2023102835.71%
Q4 20221425.00%
Q3 202231225.00%
Q2 2022173566.67%
Q1 2022131776.47%
Q4 20211313.23%
Q3 20211333.03%
Q2 2021264557.78%
Q1 20211611214.29%
Q4 202021513.33%
Q3 20208988.89%
Q2 20201615106.67%
Q1 20201310130.00%
Q4 201931717.65%
Q3 201962128.57%

0 total buy trades, and 3 total sell trades (buy/sell ratio of 0.00%) were made by Denali Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-3-
Q1 2024-15-
Q4 2023-3-
Q3 2023-17-
Q2 2023-8-
Q1 2023-24-
Q4 2022-3-
Q3 2022-10-
Q2 2022---
Q1 2022-15-
Q4 2021-30-
Q3 2021-32-
Q2 2021-35-
Q1 2021-105-
Q4 2020-11-
Q3 2020-2-
Q2 2020-14-
Q1 2020-5-
Q4 2019-14-
Q3 2019-11-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Denali Therapeutics's stocks.

Denali Therapeutics Peer Ownership


TickerCompany
SWTXSpringWorks Therapeutics, Inc.
DSGNDesign Therapeutics, Inc.
CERECerevel Therapeutics Holdings, Inc.
AKROAkero Therapeutics, Inc.
TVTXTravere Therapeutics, Inc.
BGNEBeiGene, Ltd.
FDMT4D Molecular Therapeutics, Inc.
PCVXVaxcyte, Inc.
STOKStoke Therapeutics, Inc.
BDTXBlack Diamond Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
HOWLWerewolf Therapeutics, Inc.
BCELAtreca, Inc.
RVMDRevolution Medicines, Inc. Warrant
LEGNLegend Biotech Corporation
BPMCBlueprint Medicines Corporation
GLUEMonte Rosa Therapeutics, Inc.
IKNAIkena Oncology, Inc.
APLSApellis Pharmaceuticals, Inc.
FIXXQ32 Bio Inc.
ASNDAscendis Pharma A/S
RNAAvidity Biosciences, Inc.

DNLI Ownership FAQ


Denali Therapeutics is owned by institutional shareholders (39.24%), insiders (13.71%), and public (47.04%). The largest institutional shareholder of Denali Therapeutics is BAILLIE GIFFORD & CO (10.22% of total shares) and the top mutual fund owner is BNY MELLON VARIABLE INVESTMENT FUND (0.76% of total shares).

Denali Therapeutics's major institutional shareholders are BAILLIE GIFFORD & CO, BLACKROCK INC., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, and STATE STREET CORP. The top five shareholders own together 37.71% of the company's share outstanding.

As of Mar 2024, there are 108 institutional shareholders of Denali Therapeutics.

BAILLIE GIFFORD & CO owns 14.04M shares of Denali Therapeutics, representing 10.22% of the company's total shares outstanding, valued at $288.13M (as of Mar 2024).

As of Mar 2024, BLACKROCK INC holds 12.2M shares of Denali Therapeutics (DNLI), compromising 8.88% of the company, valued at $250.34M.

VANGUARD GROUP INC is the third largest holder of Denali Therapeutics. The company owns 10.97M of the company's shares outstanding (worth $225.07M).